MERCK KGAA NAM.SP.ADR Total Liabilities

Latest as of December 2025: €22.87 Billion EUR ≈ $26.73 Billion USD

MERCK KGAA NAM.SP.ADR total liabilities. Based on the latest financial reports, MERCK KGAA NAM.SP.ADR (MRKC) has total liabilities worth €22.87 Billion EUR (≈ $26.73 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MERCK KGAA NAM.SP.ADR liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of MERCK KGAA NAM.SP.ADR (2020–2025)

Total liabilities of MERCK KGAA NAM.SP.ADR from 2020 to 2025. This chart illustrates how MERCK KGAA NAM.SP.ADR's total liabilities have evolved over time, based on quarterly financial data.

MERCK KGAA NAM.SP.ADR Competitors by Total Liabilities

The table below lists competitors of MERCK KGAA NAM.SP.ADR ranked by their total liabilities.

Company Country Total Liabilities
Powszechny Zaklad Ubezpieczen SA
WAR:PZU
Poland zł462.83 Billion
Amer Sports, Inc.
NYSE:AS
USA $3.25 Billion
Geberit AG
SW:GEBN
Switzerland CHF2.43 Billion
Brookfield Infrastructure Partners LP
NYSE:BIP
USA $90.28 Billion
RENAU.UNSP.ARD 1/5 EO-20
F:56S0
Germany €3.67 Billion
China Shipbuilding Industry Co Ltd
SHG:601989
China CN¥135.25 Billion
ASICS CORP.(UNSP.ADR)/1
F:ASI
Germany €313.13 Billion
Essex Property Trust Inc
NYSE:ESS
USA $7.47 Billion

Liability Composition Analysis (2020–2025)

This chart breaks down MERCK KGAA NAM.SP.ADR's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MERCK KGAA NAM.SP.ADR balance sheet assets.

Liquidity & Leverage Metrics

MERCK KGAA NAM.SP.ADR Total Liabilities Ratios Explained

MERCK KGAA NAM.SP.ADR total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.46 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.80 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.44 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how MERCK KGAA NAM.SP.ADR's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for MERCK KGAA NAM.SP.ADR (2020–2025)

The table below shows the annual total liabilities of MERCK KGAA NAM.SP.ADR from 2020 to 2025.

Year Total Liabilities Change
2025-12-31 €22.87 Billion
≈ $26.73 Billion
+5.96%
2024-12-31 €21.58 Billion
≈ $25.23 Billion
-0.74%
2023-12-31 €21.74 Billion
≈ $25.42 Billion
-3.51%
2022-12-31 €22.53 Billion
≈ $26.34 Billion
-5.91%
2021-12-31 €23.95 Billion
≈ $28.00 Billion
-3.36%
2020-12-31 €24.78 Billion
≈ $28.97 Billion
--

About MERCK KGAA NAM.SP.ADR

F:MRKC Germany Drug Manufacturers - Specialty & Generic
Market Cap
$17.07 Billion
€14.60 Billion EUR
Market Cap Rank
#1431 Global
#323 in Germany
Share Price
€22.60
Change (1 day)
-2.59%
52-Week Range
€20.20 - €26.20
All Time High
€44.30
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more